Viewed altogether, the data indicate that the effects of CCL5 treatment on the different breast cancer cell types are associated with enhanced metabolic activity that would support the energy and biosynthetic demands of tumour cell proliferation, migration and invasion. This evidence concerns the gene CCL5 and breast cancer.